RET(REarranged during Transfection)是一种跨膜受体酪氨酸激酶,由可溶性胶质细胞系衍生的神经营养因子 (GDNF) 家族配体 (GFL) 和糖基磷脂酰肌醇锚定辅助受体 GDNF 家族受体 α (GFRalpha) 组成的复合物激活。
RET 信号传导对于肠神经系统的发育至关重要。RET 调节交感神经、副交感神经、运动和感觉神经元的发育,并且对于多巴胺能神经元的出生后维持必不可少。RET 还在多种人类癌症中发挥驱动致癌基因的作用。在乳头状甲状腺癌、肺癌、结直肠癌、胰腺癌和乳腺癌中均检测到了 RET 与几种伴侣基因的融合,而 RET 的酪氨酸激酶抑制剂 (TKI)(尤其是 RET 特异性抑制剂)对此类癌症显示出良好的治疗效果。
RET (REarranged during Transfection) is a transmembrane receptor tyrosine kinase that is activated by a complex consisting of a soluble glial cell line-derived neurotrophic factor (GDNF) family ligand (GFL) and a glycosyl phosphatidylinositol-anchored co-receptor, GDNF family receptors alpha (GFRalpha).
RET signalling is crucial for the development of the enteric nervous system. RET regulates the development of sympathetic, parasympathetic, motor, and sensory neurons, and is necessary for the postnatal maintenance of dopaminergic neurons. RET also plays a role as a driver oncogene in a variety of human cancers. Fusion of RET with several partner genes has been detected in papillary thyroid, lung, colorectal, pancreatic, and breast cancers, and tyrosine kinase inhibitors (TKIs) for RET (particularly RET-specific inhibitors) show promising effects against such cancers.
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号